Virtu Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Virtu Financial's KNSA Position: Q3 2026 in Review
Virtu Financial reduced its Kiniksa Pharmaceuticals (KNSA) stake by 13% in Q3 2026, selling an estimated $44.2K and leaving 3,928 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #792.
Virtu Financial first reported a position in KNSA in Q4 2025 and has held it in 3 quarters since. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Virtu Financial held 3,928 shares of Kiniksa Pharmaceuticals worth $293K as of Q3 2026.
- Virtu Financial sold 601 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $44.2K.
- Kiniksa Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #792 holding.
- Virtu Financial first reported a position in Kiniksa Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.